Cartesian Therapeutics, Inc. (RNAC)

Cartesian Therapeutics Statistics

Total Valuation

RNAC has a market cap or net worth of $463.57 million. The enterprise value is $259.02 million.

Market Cap	463.57M
Enterprise Value	259.02M

Important Dates

The next estimated earnings date is Thursday, March 6, 2025, before market open.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

RNAC has 25.73 million shares outstanding.

Current Share Class	25.73M
Shares Outstanding	25.73M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+20.69%
Owned by Insiders (%)	57.91%
Owned by Institutions (%)	28.51%
Float	9.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.60
Forward PS	88.45
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.70, with a Debt / Equity ratio of 19.48.

Current Ratio	10.70
Quick Ratio	10.51
Debt / Equity	19.48
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -7,029.26% and return on invested capital (ROIC) is -224.77%.

Return on Equity (ROE)	-7,029.26%
Return on Assets (ROA)	-10.95%
Return on Capital (ROIC)	-224.77%
Revenue Per Employee	$1.26M
Profits Per Employee	-$7.43M
Employee Count	38
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	-19.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.23% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-28.23%
50-Day Moving Average	19.11
200-Day Moving Average	19.79
Relative Strength Index (RSI)	47.35
Average Volume (20 Days)	141,821

Short Selling Information

The latest short interest is 2.01 million, so 7.80% of the outstanding shares have been sold short.

Short Interest	2.01M
Short Previous Month	1.80M
Short % of Shares Out	7.80%
Short % of Float	21.35%
Short Ratio (days to cover)	16.49

Income Statement

In the last 12 months, RNAC had revenue of $47.94 million and -$282.38 million in losses. Loss per share was -$23.08.

Revenue	47.94M
Gross Profit	-1.89M
Operating Income	-40.70M
Pretax Income	-248.65M
Net Income	-282.38M
EBITDA	-39.76M
EBIT	-40.70M
Loss Per Share	-$23.08

Balance Sheet

The company has $219.20 million in cash and $14.65 million in debt, giving a net cash position of $204.55 million or $7.95 per share.

Cash & Cash Equivalents	219.20M
Total Debt	14.65M
Net Cash	204.55M
Net Cash Per Share	$7.95
Equity (Book Value)	752,000
Book Value Per Share	0.03
Working Capital	207.73M

Cash Flow

In the last 12 months, operating cash flow was -$39.96 million and capital expenditures -$8.45 million, giving a free cash flow of -$48.41 million.

Operating Cash Flow	-39.96M
Capital Expenditures	-8.45M
Free Cash Flow	-48.41M
FCF Per Share	-$1.88

Margins

Gross Margin	-3.95%
Operating Margin	-84.90%
Pretax Margin	-550.35%
Profit Margin	n/a
EBITDA Margin	-82.94%
EBIT Margin	-84.90%
FCF Margin	n/a

Dividends & Yields

RNAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-60.91%
FCF Yield	-10.44%

Analyst Forecast

The average price target for RNAC is $41.67, which is 131.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.67
Price Target Difference	131.24%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	28.95%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.0333333:1.

Last Split Date	Apr 5, 2024
Split Type	Reverse
Split Ratio	0.0333333:1

Scores

RNAC has an Altman Z-Score of -1.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.4
Piotroski F-Score	2